These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 23782331)
21. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast]. Yang G; Guo L; Jin H; Li J; Ding H Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790 [TBL] [Abstract][Full Text] [Related]
22. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329 [TBL] [Abstract][Full Text] [Related]
23. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381 [TBL] [Abstract][Full Text] [Related]
24. Lobular neoplasia: frequency and association with other breast lesions. Gomes DS; Balabram D; Porto SS; Gobbi H Diagn Pathol; 2011 Aug; 6():74. PubMed ID: 21827679 [TBL] [Abstract][Full Text] [Related]
25. The Pathologic Finding of Combined Lobular Carcinoma Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858 [TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Nayar R; Zhuang Z; Merino MJ; Silverberg SG Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790 [TBL] [Abstract][Full Text] [Related]
27. The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors. Pérez-Mies B; Caniego-Casas T; Carretero-Barrio I; Biscuola M; López-García MA; Hardisson D; Rosas M; López Rodríguez MJ; Cristóbal E; Pizarro D; Rosa-Rosa JM; Palacios J Am J Surg Pathol; 2022 Nov; 46(11):1545-1553. PubMed ID: 35877198 [TBL] [Abstract][Full Text] [Related]
28. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281 [TBL] [Abstract][Full Text] [Related]
29. Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes. Engstrøm MJ; Opdahl S; Vatten LJ; Haugen OA; Bofin AM Histopathology; 2015 Feb; 66(3):409-19. PubMed ID: 25283075 [TBL] [Abstract][Full Text] [Related]
30. Is there a low-grade precursor pathway in breast cancer? King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747 [TBL] [Abstract][Full Text] [Related]
31. [Her-2 amplification and p185 expression in invasive breast cancer cells in women]. Titi S Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393 [TBL] [Abstract][Full Text] [Related]
32. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Fackler MJ; McVeigh M; Evron E; Garrett E; Mehrotra J; Polyak K; Sukumar S; Argani P Int J Cancer; 2003 Dec; 107(6):970-5. PubMed ID: 14601057 [TBL] [Abstract][Full Text] [Related]
33. Expression patterns of beta-catenin in in situ and invasive breast cancer. Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489 [TBL] [Abstract][Full Text] [Related]
34. Incidental finding of mammary carcinoma in lumpectomy specimens. Tang P; Hajdu SI; Conte CC; Filardi DA Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895 [TBL] [Abstract][Full Text] [Related]
35. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170 [TBL] [Abstract][Full Text] [Related]
36. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
37. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Li CI; Malone KE; Saltzman BS; Daling JR Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564 [TBL] [Abstract][Full Text] [Related]
38. Expression of c-erbB3 protein in primary breast carcinomas. Naidu R; Yadav M; Nair S; Kutty MK Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984 [TBL] [Abstract][Full Text] [Related]
39. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750 [TBL] [Abstract][Full Text] [Related]
40. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction. Naidu R; Wahab NA; Yadav M; Kutty MK; Nair S Int J Mol Med; 2001 Aug; 8(2):193-8. PubMed ID: 11445874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]